Geneva, Switzerland /
The World Health Organization (WHO) gave its first emergency approval since the start of the pandemic to the Pfizer and BioNTech vaccine, which will facilitate its use in countries that have not yet validated itit said in a statement.
Regulatory experts from around the ???? reviewed the data on the Pfizer/BioNTech #COVID19 vaccine’s safety, efficacy & quality. They found that the vaccine met the must-have criteria for safety & efficacy & that the benefits of using it to address the disease offset potential risks pic.twitter.com/XSCQIDlw9b
— World Health Organization (WHO) (@WHO) December 31, 2020
“It is a very positive step to guarantee universal access to vaccines against covid-19,” he said Mariangela Simao, director in charge of access to medicines in this UN agency, according to the statement.
Some fifty countries have already started their vaccination campaign against the new coronavirus, just a year after the first alert issued by the Chinese authorities to the WHO.
The procedure also allows UNICEF, the UN agency in charge of much of the logistics of vaccine distribution around the world, and the Pan American Health Organization (PAHO) buy the vaccine for distribution in poor countries, according to the statement.
However, the doctor Mariangela Simao He stressed that “an even greater effort is needed to ensure that sufficient doses of vaccines are available to meet the needs of priority populations around the world.”
The Pfizer and BioNTech vaccine has already been injected for several weeks in the United Kingdom, but also in the European Union, the United States and Mexico, where the doses have already been applied to medical personnel.
Several million people have already been vaccinated with the drug, with an estimated efficacy of 95 percent, but which requires very low temperatures of around minus 70 degrees Celsius, making it more difficult to distribute and store.